Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS)

CUSIP: 03753U106

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
125,684,656
Total 13F shares
29,064,186
Share change
+12,025,367
Total reported value
$639,413,620
Price per share
$22.00
Number of holders
73
Value change
+$265,705,567
Number of buys
66
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 03753U106?
CUSIP 03753U106 identifies APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS) as of Q2 2018

As of 30 Jun 2018, Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (APLS) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,064,186 shares. The largest 10 holders included Hillhouse Capital Management, Ltd., Cormorant Asset Management, LP, BlackRock Inc., Sectoral Asset Management Inc, Vivo Capital, LLC, FMR LLC, VANGUARD GROUP INC, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, and VICTORY CAPITAL MANAGEMENT INC. This page lists 73 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.